BLLN BillionToOne, Inc.

NASDAQ
$90.20

BillionToOne, Inc. (BLLN) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus BLLN's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
4
96 transactions
Purchases
$0
0 shares
Sales
$26.7M
252,777 shares
Net activity
-$26.7M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $26.7M 96 transactions · 252,777 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $2.1M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 7, 2025 — 1.0 years ago, by Lynch Thomas P. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Atay Oguzhan 14 fills Chairman and CEO Sell 10b5-1 30,335 $109.93 $3.3M 143,834 −17.4% of holding
Tsao David 14 fills Chief Technology Officer Sell 10b5-1 20,000 $109.24 $2.2M 20,083 −49.9% of holding
ten Bosch John Roderick 2 fills SVP of Laboratory Operations Sell 10b5-1 2,834 $113.17 $320.7K 17,968 −13.6% of holding
Atay Oguzhan 2 fills Chairman and CEO Sell 10b5-1 11,000 $118.00 $1.3M 146,501 −7% of holding
Atay Oguzhan 5 fills Chairman and CEO Sell 10b5-1 5,150 $100.23 $516.2K 4,250 −54.8% of holding
Atay Oguzhan 3 fills Chairman and CEO Sell 10b5-1 5,850 $98.19 $574.4K 149,168 −3.8% of holding
Atay Oguzhan 6 fills Chairman and CEO Sell 10b5-1 19,334 $94.31 $1.8M 151,835 −11.3% of holding
Tsao David 11 fills Chief Technology Officer Sell 10b5-1 20,000 $108.15 $2.2M 20,134 −49.8% of holding
ten Bosch John Roderick 2 fills SVP of Laboratory Operations Sell 10b5-1 2,834 $105.15 $298.0K 20,802 −12% of holding
Atay Oguzhan 2 fills Chairman and CEO Sell 10b5-1 10,999 $120.64 $1.3M 154,502 −6.6% of holding
Tsao David Chief Technology Officer Sell 10b5-1 3,333 $125.00 $416.6K 1,000 −76.9% of holding
ten Bosch John Roderick SVP of Laboratory Operations Sell 10b5-1 1,416 $120.00 $169.9K 22,219 −6% of holding
ten Bosch John Roderick SVP of Laboratory Operations Sell 10b5-1 1,416 $106.61 $151.0K 23,635 −5.7% of holding
Lynch Thomas P. 4 fills See Remarks Sell 10b5-1 35,112 $110.33 $3.9M 16,428 −68.1% of holding
Atay Oguzhan 10 fills Chairman and CEO Sell 10b5-1 30,331 $99.91 $3.0M 159,834 −15.9% of holding
Tsao David 2 fills Chief Technology Officer Sell 10b5-1 20,000 $98.77 $2.0M 11,000 −64.5% of holding
ten Bosch John Roderick SVP of Laboratory Operations Sell 10b5-1 1,416 $97.54 $138.1K 25,051 −5.4% of holding
Lynch Thomas P. 13 fills See Remarks Sell 10b5-1 20,000 $99.99 $2.0M 20,662 −49.2% of holding
Tsao David Chief Technology Officer Sell 10b5-1 10,000 $100.00 $1.0M 1,000 −90.9% of holding
ten Bosch John Roderick SVP of Laboratory Operations Sell 10b5-1 1,417 $100.00 $141.7K 26,467 −5.1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.